GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Samsung BioLogics Co Ltd (XKRX:207940) » Definitions » EV-to-FCF

Samsung BioLogics Co (XKRX:207940) EV-to-FCF : 99.73 (As of May. 17, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Samsung BioLogics Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Samsung BioLogics Co's Enterprise Value is ₩55,938,169 Mil. Samsung BioLogics Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₩560,904 Mil. Therefore, Samsung BioLogics Co's EV-to-FCF for today is 99.73.

The historical rank and industry rank for Samsung BioLogics Co's EV-to-FCF or its related term are showing as below:

XKRX:207940' s EV-to-FCF Range Over the Past 10 Years
Min: -2907.76   Med: -73.59   Max: 1783.83
Current: 99.22

During the past 10 years, the highest EV-to-FCF of Samsung BioLogics Co was 1783.83. The lowest was -2907.76. And the median was -73.59.

XKRX:207940's EV-to-FCF is ranked worse than
87.66% of 381 companies
in the Biotechnology industry
Industry Median: 7.68 vs XKRX:207940: 99.22

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-17), Samsung BioLogics Co's stock price is ₩788000.00. Samsung BioLogics Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩12050.000. Therefore, Samsung BioLogics Co's PE Ratio for today is 65.39.


Samsung BioLogics Co EV-to-FCF Historical Data

The historical data trend for Samsung BioLogics Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsung BioLogics Co EV-to-FCF Chart

Samsung BioLogics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -167.29 1,019.82 1,784.10 -1,028.06 96.18

Samsung BioLogics Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,028.06 -434.68 433.57 537.11 96.18

Competitive Comparison of Samsung BioLogics Co's EV-to-FCF

For the Biotechnology subindustry, Samsung BioLogics Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Samsung BioLogics Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Samsung BioLogics Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Samsung BioLogics Co's EV-to-FCF falls into.



Samsung BioLogics Co EV-to-FCF Calculation

Samsung BioLogics Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=55938168.888/560903.858
=99.73

Samsung BioLogics Co's current Enterprise Value is ₩55,938,169 Mil.
Samsung BioLogics Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩560,904 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Samsung BioLogics Co  (XKRX:207940) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Samsung BioLogics Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=788000.00/12050.000
=65.39

Samsung BioLogics Co's share price for today is ₩788000.00.
Samsung BioLogics Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩12050.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Samsung BioLogics Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Samsung BioLogics Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Samsung BioLogics Co (XKRX:207940) Business Description

Traded in Other Exchanges
N/A
Address
125, Cheomdan-daero, Yeonsu-gu,, Incheon, KOR
Samsung BioLogics Co Ltd engaged in development and manufacturing of bio-healthcare products.The Company works namely in Process Development, cGMP Manufacturing, Aseptic Fill and Finish.

Samsung BioLogics Co (XKRX:207940) Headlines

No Headlines